Regulatory subunits of class IA PI3K

Current Topics in Microbiology and Immunology

Volumn 346, Issue 1, 2010, Pages 225-244

  Fruman, David A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P110ALPHA; PROTEIN P110BETA; PROTEIN P110DELTA; PROTEIN P110GAMMA; UNCLASSIFIED DRUG; GLUCOSE; PROTEIN SUBUNIT;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; DEVELOPMENT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; ENZYME STRUCTURE; GENE TARGETING; GLUCOSE HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; CHEMISTRY; IMMUNITY; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; REVIEW;

ANIMALS; ENZYME ACTIVATION; GLUCOSE; HUMANS; IMMUNITY; NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN STRUCTURE, TERTIARY; PROTEIN SUBUNITS;

EID: 79952112367     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82-2010-39     Document Type: Article

References (98)

1. Alcazar I, Cortes I, Zaballos A, Hernandez C, Fruman DA, Barber DF, Carrera AC (2009) p85Beta phosphoinositide 3-kinase regulates CD28 coreceptor function. Blood 113:3198-3208
2. Baier LJ, Wiedrich C, Hanson RL, Bogardus C (1998) Variant in the regulatory subunit of phosphatidylinositol 3-kinase (p85alpha): preliminary evidence indicates a potential roleof this variant in the acute insulin response and type 2 diabetes in Pima women. Diabetes 47:973-975 (Pubitemid 28255675)
3. Bandyopadhyay GK, Yu JG, Ofrecio J, Olefsky JM (2005) Increased p85/55/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skeletal muscle. Diabetes 54:2351-2359 (Pubitemid 41134262)
4. Barber DF, Bartolome A, Hernandez C, Flores JM, Fernandez-Arias C, Rodriguez-Borlado L, Hirsch E, Wymann M, Balomenos D, Carrera AC (2006) Class IB-phosphatidylinositol 3-kinase (PI3K) deficiency ameliorates IA-PI3K-induced systemic lupus but not T cell invasion. J Immunol 176:589-593 (Pubitemid 43023307)
5. Bilancio A, Okkenhaug K, Camps M, Emery JL, Ruckle T, Rommel C, Vanhaesebroeck B (2006) Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells. Blood 107:642-650 (Pubitemid 43076389)
6. Borlado LR, Redondo C, Alvarez B, Jimenez C, Criado LM, Flores J, Marcos MA, Martinez AC, Balomenos D, Carrera AC (2000) Increased phosphoinositide 3-kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo. FASEB J 14:895-903 (Pubitemid 30241666)
7. Brachmann SM, Yballe CM, Innocenti M, Deane JA, Fruman DA, Thomas SM, Cantley LC (2005) Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement. Mol Cell Biol 25:2593-2606 (Pubitemid 40381624)
8. Chamberlain MD, Berry TR, Pastor MC, Anderson DH (2004) The p85alpha subunit of phosphatidylinositol 30-kinase binds to and stimulates the GTPase activity of Rab proteins. J Biol Chem 279:48607-48614 (Pubitemid 39625735)
9. Chen D, Mauvais-Jarvis F, Bluher M, Fisher SJ, Jozsi A, Goodyear LJ, Ueki K, Kahn CR (2004) p50alpha/p55alpha phosphoinositide 3-kinase knockout mice exhibit enhanced insulin sensitivity. Mol Cell Biol 24:320-329 (Pubitemid 38010057)
10. Deane JA, Fruman DA (2004) Phosphoinositide 3-kinase: diverse roles in immune cell activation. Annu Rev Immunol 22:563-598 (Pubitemid 38680434)
11. Deane JA, Trifilo MJ, Yballe CM, Choi S, Lane TE, Fruman DA (2004) Enhanced T cell proliferation in mice lacking the p85beta subunit of phosphoinositide 3-kinase. J Immunol 172:6615-6625 (Pubitemid 38669096)
12. Deane JA, Kharas MG, Oak JS, Stiles LN, Luo J, Moore TI, Ji H, Rommel C, Cantley LC, Lane TE, Fruman DA (2007) T cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling. Blood 109:2894-2902 (Pubitemid 46482086)
13. Dhand R, Hara K, Hiles I, Bax B, Gout I, Panayotou G, Fry MJ, Yonezawa K, Kasuga M, Waterfield MD (1994) PI 3-kinase: structural and functional analysis of intersubunit interactions. EMBO J 13:511-521 (Pubitemid 24050665)
14. Donahue AC, Hess KL, Ng KL, Fruman DA (2004) Altered splenic B cell subset development in mice lacking phosphoinositide 3-kinase p85alpha. Int Immunol 16:1789-1798 (Pubitemid 40003867)
15. End P, Gout I, Fry MJ, Panayotou G, Dhand R, Yonezawa K, Kasuga M, Waterfield MD (1993) A biosensor approach to probe the structure and function of the p85 alpha subunit of the phosphatidylinositol 3-kinase complex. J Biol Chem 268:10066-10075 (Pubitemid 23150183)
16. Fabre S, Lang V, Harriague J, Jobart A, Unterman TG, Trautmann A, Bismuth G (2005) Stable activation of phosphatidylinositol 3-kinase in the T cell immunological synapse stimulates Akt signaling to FoxO1 nuclear exclusion and cell growth control. J Immunol 174:4161-4171 (Pubitemid 40395994)
17. Fos C, Salles A, Lang V, Carrette F, Audebert S, Pastor S, Ghiotto M, Olive D, Bismuth G, Nunes JA (2008) ICOS ligation recruits the p50alpha PI3K regulatory subunit to the immunological synapse. J Immunol 181:1969-1977
18. Foukas LC, ClaretM, PearceW, Okkenhaug K, Meek S, Peskett E, Sancho S, Smith AJ,Withers DJ, Vanhaesebroeck B (2006) Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature 441:366-370 (Pubitemid 44050203)
19. Fruman DA, Cantley LC, Carpenter CL (1996) Structural organization and alternative splicing of the murine phosphoinositide 3-kinase p85 alpha gene. Genomics 37:113-121 (Pubitemid 26341841)
20. Fruman DA, Meyers RE, Cantley LC (1998) Phosphoinositide kinases. Annu Rev Biochem 67:481-507 (Pubitemid 28411136)
21. Fruman DA, Snapper SB, Yballe CM, Davidson L, Yu JY, Alt FW, Cantley LC (1999) Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. Science 283:393-397
22. Fruman DA, Mauvais-Jarvis F, Pollard DA, Yballe CM, Brazil D, Bronson RT, Kahn CR, Cantley LC (2000a) Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha. Nat Genet 26:379-382
23. Fruman DA, Satterthwaite AB, Witte ON (2000b) Xid-like phenotypes: a B cell signalosome takes shape. Immunity 13:1-3
24. Fu Z, Aronoff-Spencer E, Backer JM, Gerfen GJ (2003) The structure of the inter-SH2 domain of class IA phosphoinositide 3-kinase determined by site-directed spin labeling EPR and homology modeling. Proc Natl Acad Sci USA 100:3275-3280 (Pubitemid 36356573)
25. Fukao T, Tanabe M, Terauchi Y, Ota T, Matsuda S, Asano T, Kadowaki T, Takeuchi T, Koyasu S (2002a) PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat Immunol 3:875-881
26. Fukao T, Yamada T, TanabeM, TerauchiY,Ota T, Takayama T, Asano T, Takeuchi T,Kadowaki T, Hata Ji J, Koyasu S (2002b) Selective loss of gastrointestinalmast cells and impaired immunity in PI3K-deficient mice. Nat Immunol 3:295-304 (Pubitemid 34213432)
27. Garcia Z, Silio V, Marques M, Cortes I, Kumar A, Hernandez C, Checa AI, Serrano A, Carrera AC (2006) A PI3K activity-independent function of p85 regulatory subunit in control of mammalian cytokinesis. EMBO J 25:4740-4751 (Pubitemid 44607020)
28. Geering B, Cutillas PR, Nock G, Gharbi SI, Vanhaesebroeck B (2007) Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers. Proc Natl Acad Sci USA 104:7809-7814 (Pubitemid 47185833)
29. Gupta S, Ramjaun AR, Haiko P, Wang Y, Warne PH, Nicke B, Nye E, Stamp G, Alitalo K, Downward J (2007) Binding of ras to phosphoinositide 3-kinase p110alpha is required for rasdriven tumorigenesis in mice. Cell 129:957-968 (Pubitemid 46802703)
30. Gymnopoulos M, Elsliger MA, Vogt PK (2007) Rare cancer-specific mutations in PIK3CA show gain of function. Proc Natl Acad Sci USA 104:5569-5574 (Pubitemid 47175721)
31. Hartley D, Meisner H, Corvera S (1995) Specific association of the beta isoform of the p85 subunit of phosphatidylinositol-3 kinase with the proto-oncogene c-cbl. J Biol Chem 270:18260-18263
32. Hawkins PT, Stephens LR, Suire S, Wilson M (2010) PI3K Signaling in Neutrophils. Curr Top Microbiol Immunol doi 10.1007/82-2010-40
33. Hess KL, Donahue AC, Ng KL, Moore TI, Oak J, Fruman DA (2004) Frontline: the p85alpha isoform of phosphoinositide 3-kinase is essential for a subset of B cell receptor-initiated signaling responses. Eur J Immunol 34:2968-2976 (Pubitemid 39549376)
34. Hill KM, Huang Y, Yip SC, Yu J, Segall JE, Backer JM (2001) N-terminal domains of the class IA phosphoinositide 3-kinase regulatory subunit play a role in cytoskeletal but not mitogenic signaling. J Biol Chem 276:16374-16378
35. Huang CH, MandelkerD, Schmidt-Kittler O, SamuelsY,VelculescuVE, Kinzler KW, Vogelstein B, Gabelli SB, Amzel LM(2007) The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations. Science 318:1744-1748 (Pubitemid 350274378)
36. Huddleston H, Tan B, Yang FC, White H, Wenning MJ, Orazi A, Yoder MC, Kapur R, Ingram DA (2003) Functional p85alpha gene is required for normal murine fetal erythropoiesis. Blood 102:142-145 (Pubitemid 36759647)
37. Inukai K, Anai M, Van Breda E, Hosaka T, Katagiri H, Funaki M, Fukushima Y, Ogihara T, Yazaki Y, Kikuchi OY, Asano T (1996) A novel 55-kDa regulatory subunit for phosphatidylinositol 3-kinase structurally similar to p55PIK is generated by alternative splicing of the p85alpha gene. J Biol Chem 271:5317-5320
38. Jaiswal BS, Janakiraman V, Kljavin NM, Chaudhuri S, Stern HM, Wang W, Kan Z, Dbouk HA, Peters BA, Waring P, Dela Vega T, Kenski DM, Bowman KK, Lorenzo M, Li H, Wu J, Modrusan Z, Stinson J, Eby M, Yue P, Kaminker JS, de Sauvage FJ, Backer JM, Seshagiri S (2009) Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation. Cancer cell 16:463-474
39. Janssen JW, Schleithoff L, Bartram CR, Schulz AS (1998) An oncogenic fusion product of the phosphatidylinositol 3-kinase p85beta subunit and HUMORF8, a putative deubiquitinating enzyme. Oncogene 16:1767-1772 (Pubitemid 28175058)
40. Jimenez C, Jones DR, Rodriguez-Viciana P, Gonzalez-Garcia A, Leonardo E, Wennstrom S, von Kobbe C, Toran JL, R-Borlado L, Calvo V, Copin SG, Albar JP, Gaspar ML, Diez E, Marcos MA, Downward J, Martinez AC, Merida I, Carrera AC (1998) Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase. EMBO J 17:743-753 (Pubitemid 28062053)
41. Jimenez C, Portela RA, Mellado M, Rodriguez-Frade JM, Collard J, Serrano A, Martinez AC, Avila J, Carrera AC (2000) Role of the PI3K regulatory subunit in the control of actin organization and cell migration. J Cell Biol 151:249-262
42. Jimenez C, Hernandez C, Pimentel B, Carrera AC (2002) The p85 regulatory subunit controls sequential activation of phosphoinositide 3-kinase by Tyr kinases and Ras. J Biol Chem 277:41556-41562 (Pubitemid 35257459)
43. Kang S, Bader AG, Zhao L, Vogt PK (2005) Mutated PI 3-kinases: cancer targets on a silver platter. Cell cycle 4:578-581 (Pubitemid 41359785)
44. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H, Betsholtz C, Alitalo K (2004) Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5:74-80 (Pubitemid 38081471)
45. Kharas MG, Deane JA, Wong S, O'Bosky KR, Rosenberg N, Witte ON, Fruman DA (2004) Phosphoinositide 3-kinase signaling is essential for ABL oncogene-mediated transformation of B-lineage cells. Blood 103:4268-4275 (Pubitemid 38685373)
46. Kharas MG, Janes MR, Scarfone VM, Lilly MB, Knight ZA, Shokat KM, Fruman DA (2008) Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells. J Clin Invest 118:3038-3050
47. Kirwan JP, Varastehpour A, Jing M, Presley L, Shao J, Friedman JE, Catalano PM (2004) Reversal of insulin resistance postpartum is linked to enhanced skeletal muscle insulin signaling. J Clin Endocrinol Metab 89:4678-4684 (Pubitemid 39244488)
48. Kok K, Geering B, Vanhaesebroeck B (2009) Regulation of phosphoinositide 3-kinase expression in health and disease. Trends Biochem Sci 34:115-127
49. Koyasu S (2003) The role of PI3K in immune cells. Nat Immunol 4:313-319
50. Lin X, Bohle AS, Dohrmann P, Leuschner I, Schulz A, Kremer B, Fandrich F (2001) Overexpression of phosphatidylinositol 3-kinase in human lung cancer. Langenbeck's Arch Surg 386:293-301 (Pubitemid 32702759)
51. Lu-Kuo JM, Fruman DA, Joyal DM, Cantley LC, Katz HR (2000) Impaired kit-but not FcepsilonRI-initiated mast cell activation in the absence of phosphoinositide 3-kinase p85alpha gene products. J Biol Chem 275:6022-6029 (Pubitemid 30115253)
52. Luo J, Cantley LC (2005) The negative regulation of phosphoinositide 3-kinase signaling by p85 and it's implication in cancer. Cell cycle 4:1309-1312 (Pubitemid 41437108)
53. Luo J, Field SJ, Lee JY, Engelman JA, Cantley LC (2005a) The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex. J Cell Biol 170:455-464 (Pubitemid 41126944)
54. Luo J, Sobkiw CL, Logsdon NM, Watt JM, Signoretti S, O'Connell F, Shin E, Shim Y, Pao L, Neel BG, Depinho RA, Loda M, Cantley LC (2005b) Modulation of epithelial neoplasia and lymphoid hyperplasia in PTEN+/-mice by the p85 regulatory subunits of phosphoinositide 3-kinase. Proc Natl Acad Sci USA 102:10238-10243 (Pubitemid 41023356)
55. Luo J, Sobkiw CL, Hirshman MF, Logsdon MN, Li TQ, Goodyear LJ, Cantley LC (2006) Loss of class IA PI3K signaling in muscle leads to impaired muscle growth, insulin response, and hyperlipidemia. Cell Metab 3:355-366
56. Mauvais-Jarvis F, Ueki K, Fruman DA, Hirshman MF, Sakamoto K, Goodyear LJ, Iannacone M, Accili D, Cantley LC, Kahn CR (2002) Reduced expression of the murine p85alpha subunit ofphosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes. J Clin Invest 109:141-149 (Pubitemid 34052550)
57. Miled N, Yan Y, Hon WC, Perisic O, Zvelebil M, Inbar Y, Schneidman-Duhovny D, Wolfson HJ, Backer JM, Williams RL (2007) Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit. Science 317:239-242 (Pubitemid 47076198)
58. Miyake K, Ogawa W, Matsumoto M, Nakamura T, Sakaue H, Kasuga M (2002) Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver. J Clin Invest 110:1483-1491 (Pubitemid 35396919)
59. Mouta-Bellum C, Kirov A, Miceli-Libby L, Mancini ML, Petrova TV, Liaw L, Prudovsky I, Thorpe PE, Miura N, Cantley LC, Alitalo K, Fruman DA, Vary CP (2009) Organ-specific lymphangiectasia, arrested lymphatic sprouting, and maturation defects resulting from genetargeting of the PI3K regulatory isoforms p85alpha, p55alpha, and p50alpha. Dev Dyn 238:2670-2679
60. Munugalavadla V, Sims EC, Borneo J, Chan RJ, Kapur R (2007) Genetic and pharmacologic evidence implicating the p85 alpha, but not p85 beta, regulatory subunit of PI3K and Rac2 GTPase in regulating oncogenic KIT-induced transformation in acute myeloid leukemia and systemic mastocytosis. Blood 110:1612-1620 (Pubitemid 47443979)
61. Oak JS, Deane JA, Kharas MG, Luo J, Lane TE, Cantley LC, Fruman DA (2006) Sjogren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase. Proc Natl Acad Sci USA 103:16882-16887 (Pubitemid 44737347)
62. Oak JS, Chen J, Peralta RQ, Deane JA, Fruman DA (2009) The p85b regulatory subunit of phosphoinositide 3-kinase has unique and redundant functions in B cells. Autoimmunity 42:447-458
63. Okkenhaug K, Vanhaesebroeck B (2001) New responsibilities for the PI3K regulatory subunit p85 alpha. Sci STKE 2001:PE1
64. Okkenhaug K, Vanhaesebroeck B (2003) PI3K in lymphocyte development, differentiation and activation. Nat Rev Immunol 3:317-330 (Pubitemid 37328684)
65. Okkenhaug K, Patton DT, Bilancio A, Garcon F, Rowan WC, Vanhaesebroeck B (2006) The p110delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells. J Immunol 177:5122-5128 (Pubitemid 44527583)
66. Park SW, Zhou Y, Lee J, Lu A, Sun C, Chung J, Ueki K, Ozcan U (2010) The regulatory subunits of PI3K, p85alpha and p85beta, interact with XBP-1 and increase its nuclear translocation. Nat Med 16:429-437
67. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA Jr., Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, RigginsGJ, BignerDD,Karchin R, Papadopoulos N, Parmigiani G,Vogelstein B, VelculescuVE, Kinzler KW(2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807-1812
68. Philp AJ, Campbell IG, Leet C, Vincan E, Rockman SP, Whitehead RH, Thomas RJ, Phillips WA (2001) The phosphatidylinositol 30-kinase p85alpha gene is an oncogene in human ovarian and colon tumors. Cancer Res 61:7426-7429 (Pubitemid 32995029)
69. Pleiman CM, Hertz WM, Cambier JC (1994) Activation of phosphatidylinositol-30 kinase by Srcfamily kinase SH3 binding to the p85 subunit. Science 263:1609-1612
70. Pons S, Asano T, Glasheen E, Miralpeix M, Zhang Y, Fisher TL, Myers MG Jr., Sun XJ, White MF (1995) The structure and function of p55PIK reveal a new regulatory subunit for phosphatidylinositol 3-kinase. Mol Cell Biol 15:4453-4465
71. Reynolds LF, Smyth LA, Norton T, Freshney N, Downward J, Kioussis D, Tybulewicz VL (2002) Vav1 transduces T cell receptor signals to the activation of phospholipase C-gamma1 via phosphoinositide 3-kinase-dependent and -independent pathways. J Exp Med 195:1103-1114 (Pubitemid 34517137)
72. Rodriguez-Viciana P, Sabatier C,McCormick F (2004) Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate. Mol Cell Biol 24:4943-4954 (Pubitemid 38668058)
73. Rommel C, Camps M, Ji H (2007) PI3Kdelta and PI3Kgamma: partners in crime in inflammation in rheumatoid arthritis and beyond? Nat Rev Drug Discov 7:191-201
74. Rychahou PG, Murillo CA, Evers BM (2005) Targeted RNA interference of PI3K pathway components sensitizes colon cancer cells to TNF-related apoptosis-inducing ligand (TRAIL). Surgery 138:391-397 (Pubitemid 41253826)
75. Shukla S, Maclennan GT, Hartman DJ, Fu P, Resnick MI, Gupta S (2007) Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion. Int J Cancer 121:1424-1432 (Pubitemid 47328700)
76. Soltoff SP, Cantley LC (1996) p120cbl is a cytosolic adapter protein that associates with phosphoinositide 3-kinase in response to epidermal growth factor in PC12 and other cells. J Biol Chem 271:563-567
77. Stahl U, Wenk J, Wagener F, Woenckhaus J, Gamerdinger U, Battmann A, Dreyer T (2004) Phosphoinositide 3-kinase (PI3-K) expression. Tumorigenesis of epithelial carcinoma of the mouth. Pathologe 25:31-37 (Pubitemid 38235206)
78. Suzuki H, Terauchi Y, Fujiwara M, Aizawa S, Yazaki Y, Kadowaki T, Koyasu S (1999) Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. Science 283:390-392
79. Suzuki H, Matsuda S, Terauchi Y, Fujiwara M, Ohteki T, Asano T, Behrens TW, Kouro T, Takatsu K, Kadowaki T, Koyasu S (2003) PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction. Nat Immunol 4:280-286 (Pubitemid 36322139)
80. Taniguchi CM, Tran TT, Kondo T, Luo J, Ueki K, Cantley LC, Kahn CR (2006a) Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN. Proc Natl Acad Sci USA 103:12093-12097 (Pubitemid 44215816)
81. Taniguchi CM, Kondo T, Sajan M, Luo J, Bronson R, Asano T, Farese R, Cantley LC, Kahn CR (2006b) Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKClambda/zeta. Cell Metab 3:343-353
82. Taniguchi CM, Aleman JO, Ueki K, Luo J, Asano T, Kaneto H, Stephanopoulos G, Cantley LC, Kahn CR (2007) The p85alpha regulatory subunit of phosphoinositide 3-kinase potentiates c-Jun N-terminal kinase-mediated insulin resistance. Mol Cell Biol 27:2830-2840 (Pubitemid 46581299)
83. Terauchi Y, Tsuji Y, Satoh S, Minoura H, Murakami K, Okuno A, Inukai K, Asano T, Kaburagi Y, Ueki K, Nakajima H, Hanafusa T, Matsuzawa Y, Sekihara H, Yin Y, Barrett JC, Oda H, Ishikawa T, Akanuma Y, Komuro I, Suzuki M, Yamamura K, Kodama T, Suzuki H, Yamamura K, Kodama T, Suzuki H, Koyasu S, Aizawa S, Tobe K, Fukui Y, Yazaki Y, Kadowaki T (1999) Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphoinositide 3-kinase. Nat Genet 21:230-235 (Pubitemid 29070374)
84. The Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061-1068
85. Ueki K, Yballe CM, Brachmann SM, Vicent D, Watt JM, Kahn CR, Cantley LC (2002a) Increased insulin sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase. Proc Natl Acad Sci USA 99:419-424 (Pubitemid 34060376)
86. Ueki K, Fruman DA, Brachmann SM, Tseng YH, Cantley LC, Kahn CR (2002b) Molecular balance between the regulatory and catalytic subunits of phosphoinositide 3-kinase regulates cell signaling and survival. Mol Cell Biol 22:965-977 (Pubitemid 34053073)
87. Ueki K, Fruman DA, Yballe CM, Fasshauer M, Klein J, Asano T, Cantley LC, Kahn CR (2003) Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling. J Biol Chem 278:48453-48466 (Pubitemid 37523301)
88. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC, Woscholski R, Parker PJ, Waterfield MD (2001) Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 70:535-602 (Pubitemid 32662219)
89. Vanhaesebroeck B, Ali K, Bilancio A, Geering B, Foukas LC (2005) Signalling by PI3K isoforms: insights from gene-targeted mice. Trends Biochem Sci 30:194-204 (Pubitemid 40463309)
90. Vigorito E, Bardi G, Glassford J, Lam EW, Clayton E, Turner M (2004) Vav-dependent and vavindependent phosphatidylinositol 3-kinase activation in murine B cells determined by the nature of the stimulus. J Immunol 173:3209-3214 (Pubitemid 39142028)
91. Walmsley MJ, Ooi SK, Reynolds LF, Smith SH, Ruf S, Mathiot A, Vanes L, Williams DA, Cancro MP, Tybulewicz VL (2003) Critical roles for Rac1 and Rac2 GTPases in B cell development and signaling. Science 302:459-462 (Pubitemid 37296274)
92. Watanabe N, Nakajima H, Suzuki H, Oda A, Matsubara Y, Moroi M, Terauchi Y, Kadowaki T, Suzuki H, Koyasu S, Ikeda Y, Handa M (2003) Functional phenotype of phosphoinositide 3-kinase p85alpha-null platelets characterized by an impaired response to GP VI stimulation. Blood 102:541-548 (Pubitemid 36841973)
93. Wetzker R, Rommel C (2004) Phosphoinositide 3-kinases as targets for therapeutic intervention. Curr Pharm Design 10:1915-1922 (Pubitemid 38647577)
94. Winnay JN, Boucher J, Mori MA, Ueki K, Kahn CR (2010) A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box-binding protein-1 to modulate the unfolded protein response. Nat Med 16:438-445
95. Wu H, Shekar SC, Flinn RJ, El-SibaiM, Jaiswal BS, Sen KI, Janakiraman V, Seshagiri S, Gerfen GJ, Girvin ME, Backer JM (2009) Regulation of Class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110alpha and are disrupted in oncogenic p85 mutants. Proc Natl Acad Sci USA 106:20258-20263
96. Wymann MP, Zvelebil M, Laffargue M (2003) Phosphoinositide 3-kinase signalling -which way to target? Trends Pharmacol Sci 24:366-376 (Pubitemid 37315529)
97. Yang FC, Chen S, Robling AG, Yu X, Nebesio TD, Yan J, Morgan T, Li X, Yuan J, Hock J, Ingram DA, Clapp DW (2006) Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions. J Clin Invest 116:2880-2891 (Pubitemid 44684473)
98. Yu J, Zhang Y, McIlroy J, Rordorf-Nikolic T, Orr GA, Backer JM (1998) Regulation of the p85/ p110 phosphatidylinositol 30-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit. Mol Cell Biol 18:1379-1387 (Pubitemid 28100902)